Helen M Parry

May 9, 2024 | nature.com | Helen M Parry |Paul Moss

B cell chronic lymphocytic leukemia (B-CLL) is a common leukemia subtype [1] and compromised immune function is a major clinical problem leading to increased mortality among patients [2]. Natural killer (NK) cells recognize and kill transformed or virally infected cells through mechanisms including granule-mediated cell lysis, cytokine release, and antibody-dependent cell-mediated cytotoxicity (ADCC) [3, 4].